94 related articles for article (PubMed ID: 32027982)
1. Targeting Ku86 enhances X-ray-induced radiotherapy sensitivity in serous ovarian cancer cells.
Ma Q; Kai J; Liu Y; Tong Y; Xie S; Zheng H; Wang Y; Guo L; Lu R
Int J Biochem Cell Biol; 2020 Apr; 121():105705. PubMed ID: 32027982
[TBL] [Abstract][Full Text] [Related]
2. Influence of Ku86 and XRCC4 expression in uterine cervical cancer on the response to preoperative radiotherapy.
Takada Y; Someya M; Matsumoto Y; Satoh M; Nakata K; Hori M; Saito M; Hirokawa N; Tateoka K; Teramoto M; Saito T; Hasegawa T; Sakata KI
Med Mol Morphol; 2016 Dec; 49(4):210-216. PubMed ID: 26867665
[TBL] [Abstract][Full Text] [Related]
3. The lethality of Ku86 (XRCC5) loss-of-function mutations in human cells is independent of p53 (TP53).
Ghosh G; Li G; Myung K; Hendrickson EA
Radiat Res; 2007 Jan; 167(1):66-79. PubMed ID: 17214517
[TBL] [Abstract][Full Text] [Related]
4. 53BP1 contributes to survival of cells irradiated with X-ray during G1 without Ku70 or Artemis.
Iwabuchi K; Hashimoto M; Matsui T; Kurihara T; Shimizu H; Adachi N; Ishiai M; Yamamoto K; Tauchi H; Takata M; Koyama H; Date T
Genes Cells; 2006 Aug; 11(8):935-48. PubMed ID: 16866876
[TBL] [Abstract][Full Text] [Related]
5. The major DNA repair pathway after both proton and carbon-ion radiation is NHEJ, but the HR pathway is more relevant in carbon ions.
Gerelchuluun A; Manabe E; Ishikawa T; Sun L; Itoh K; Sakae T; Suzuki K; Hirayama R; Asaithamby A; Chen DJ; Tsuboi K
Radiat Res; 2015 Mar; 183(3):345-56. PubMed ID: 25738894
[TBL] [Abstract][Full Text] [Related]
6. Influence of XRCC4 expression in esophageal cancer cells on the response to radiotherapy.
Hori M; Someya M; Matsumoto Y; Nakata K; Kitagawa M; Hasegawa T; Tsuchiya T; Fukushima Y; Gocho T; Sato Y; Ohnuma H; Kato J; Sugita S; Hasegawa T; Sakata KI
Med Mol Morphol; 2017 Mar; 50(1):25-33. PubMed ID: 27338590
[TBL] [Abstract][Full Text] [Related]
7. An antisense oligonucleotide targeted to human Ku86 messenger RNA sensitizes M059K malignant glioma cells to ionizing radiation, bleomycin, and etoposide but not DNA cross-linking agents.
Belenkov AI; Paiement JP; Panasci LC; Monia BP; Chow TY
Cancer Res; 2002 Oct; 62(20):5888-96. PubMed ID: 12384553
[TBL] [Abstract][Full Text] [Related]
8. Translocation of Ku86/Ku70 to the multiple myeloma cell membrane: functional implications.
Tai YT; Podar K; Kraeft SK; Wang F; Young G; Lin B; Gupta D; Chen LB; Anderson KC
Exp Hematol; 2002 Mar; 30(3):212-20. PubMed ID: 11882358
[TBL] [Abstract][Full Text] [Related]
9. Ku86 modulates DNA topoisomerase I-mediated radiosensitization, but not cytotoxicity, in mammalian cells.
Shih SJ; Erbele T; Chen AY
Cancer Res; 2005 Oct; 65(20):9194-9. PubMed ID: 16230379
[TBL] [Abstract][Full Text] [Related]
10. Blocking the DNA repair system by traditional Chinese medicine?
Sun MF; Chang TT; Chang KW; Huang HJ; Chen HY; Tsai FJ; Lin JG; Chen CY
J Biomol Struct Dyn; 2011 Jun; 28(6):895-906. PubMed ID: 21469750
[TBL] [Abstract][Full Text] [Related]
11. Heat shock factor 1, an inhibitor of non-homologous end joining repair.
Kang GY; Kim EH; Lee HJ; Gil NY; Cha HJ; Lee YS
Oncotarget; 2015 Oct; 6(30):29712-24. PubMed ID: 26359349
[TBL] [Abstract][Full Text] [Related]
12. [DNA damage response of epithelial ovarian cancer cells (primary culture) to chemo-radiotherapy].
Wang S; Guo LD; Jia YG; Yang J; Wang X; Liu C; Lou JY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 Mar; 45(2):185-91. PubMed ID: 24749337
[TBL] [Abstract][Full Text] [Related]
13. The nonhomologous DNA end joining pathway is important for chromosome stability in primary fibroblasts.
Karanjawala ZE; Grawunder U; Hsieh CL; Lieber MR
Curr Biol; 1999 Dec 16-30; 9(24):1501-4. PubMed ID: 10607596
[TBL] [Abstract][Full Text] [Related]
14. Transfer of Ku86 RNA antisense decreases the radioresistance of human fibroblasts.
Marangoni E; Le Romancer M; Foray N; Muller C; Douc-Rasy S; Vaganay S; Abdulkarim B; Barrois M; Calsou P; Bernier J; Salles B; Bourhis J
Cancer Gene Ther; 2000 Feb; 7(2):339-46. PubMed ID: 10770645
[TBL] [Abstract][Full Text] [Related]
15. Heterozygous inactivation of human Ku70/Ku86 heterodimer does not affect cell growth, double-strand break repair, or genome integrity.
Uegaki K; Adachi N; So S; Iiizumi S; Koyama H
DNA Repair (Amst); 2006 Mar; 5(3):303-11. PubMed ID: 16325483
[TBL] [Abstract][Full Text] [Related]
16. Ku86 is essential in human somatic cells.
Li G; Nelsen C; Hendrickson EA
Proc Natl Acad Sci U S A; 2002 Jan; 99(2):832-7. PubMed ID: 11792868
[TBL] [Abstract][Full Text] [Related]
17. Polyethyleneimine grafted with pluronic P85 enhances Ku86 antisense delivery and the ionizing radiation treatment efficacy in vivo.
Belenkov AI; Alakhov VY; Kabanov AV; Vinogradov SV; Panasci LC; Monia BP; Chow TY
Gene Ther; 2004 Nov; 11(22):1665-72. PubMed ID: 15470482
[TBL] [Abstract][Full Text] [Related]
18. Developmental cell death in the liver and newborn lethality of Ku86 deficient mice suppressed by antioxidant N-acetyl-cysteine.
Reliene R; Goad ME; Schiestl RH
DNA Repair (Amst); 2006 Nov; 5(11):1392-7. PubMed ID: 16916625
[TBL] [Abstract][Full Text] [Related]
19. Flavopiridol, a cyclin-dependent kinase inhibitor, enhances radiosensitivity of ovarian carcinoma cells.
Raju U; Nakata E; Mason KA; Ang KK; Milas L
Cancer Res; 2003 Jun; 63(12):3263-7. PubMed ID: 12810657
[TBL] [Abstract][Full Text] [Related]
20. TAS-116, a Novel Hsp90 Inhibitor, Selectively Enhances Radiosensitivity of Human Cancer Cells to X-rays and Carbon Ion Radiation.
Lee Y; Sunada S; Hirakawa H; Fujimori A; Nickoloff JA; Okayasu R
Mol Cancer Ther; 2017 Jan; 16(1):16-24. PubMed ID: 28062703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
